These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 34197005

  • 21. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
    Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.
    Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
    [Abstract] [Full Text] [Related]

  • 22. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ.
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [Abstract] [Full Text] [Related]

  • 23. Analysis of specificity of anti-human leukocyte antigen antibodies in kidney recipients in reference to clinical outcome.
    Nowosiad-Magda M, Myślak M, Roszkowska P, Borowiec-Chłopek Z, Urasińska E, Różański J, Domański L, Ciechanowski K, Giedrys-Kalemba S.
    Transplant Proc; 2014 Oct; 46(8):2606-12. PubMed ID: 25380877
    [Abstract] [Full Text] [Related]

  • 24. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G, Collaborative Transplant Study Report.
    Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065
    [Abstract] [Full Text] [Related]

  • 25. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.
    Kincaide E, Hitchman K, Hall R, Yamaguchi I, Ding Y, Crowther B.
    Pediatr Transplant; 2019 Dec; 23(8):e13590. PubMed ID: 31617318
    [Abstract] [Full Text] [Related]

  • 26. Donor non-specific MICA antibodies in renal transplant recipients.
    Sapák M, Chreňová S, Tirpáková J, Žilinská Z, Ďurmanová V, Shawkatová I, Jakuš V, Kuba D, Buc M.
    Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943
    [Abstract] [Full Text] [Related]

  • 27. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J, Mihatsch MJ, Dragun D, Schaub S.
    Transplantation; 2008 Jun 15; 85(11):1557-63. PubMed ID: 18551059
    [Abstract] [Full Text] [Related]

  • 34. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y, Ozdilli K, Oguz F, Karahan G, Onal E, Turkmen A, Eldegez U, Nane I, Çalişkan Y, Bakkaloglu H, Carin M.
    Transplant Proc; 2012 Jun 15; 44(6):1660-6. PubMed ID: 22841239
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H, Min JW, Kim JI, Moon IS, Park KH, Yang CW, Chung BH, Oh EJ.
    Medicine (Baltimore); 2016 Mar 15; 95(11):e3094. PubMed ID: 26986147
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Transpl Immunol; 2015 Mar 15; 32(2):66-71. PubMed ID: 25661873
    [Abstract] [Full Text] [Related]

  • 39. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF, Chadha V, Warady BA.
    Pediatr Transplant; 2016 Nov 15; 20(7):926-930. PubMed ID: 27448994
    [Abstract] [Full Text] [Related]

  • 40. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May 15; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.